NCT04743141

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2021-04-28Est. Completion: 2030-07-31

Enrollment target: 600 participants

Locations

Perseverance Research Center, LLC, Scottsdale, Arizona, United States
Physicians Research Group, Tempe, Arizona, United States
Advanced Research Center, Inc., Anaheim, California, United States
ProScience Research Group, Culver City, California, United States
Neuro-Pain Research Center, Fresno, California, United States
Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla, California, United States
Adult & Child Neurology Medical Associates, Long Beach, California, United States
Memorialcare Miller Children's & Women's Hospital Long Beach, Long Beach, California, United States
Velocity Clinical Research - North Hollywood, North Hollywood, California, United States
The Neurology Group, Pomona, California, United States
UC Davis Medical Center, Investigational Drug Service (IDS) Pharmacy, Sacramento, California, United States
University of California, Davis Clinical and Translational Science Center Clinical Research Center, Sacramento, California, United States
University of California, Davis Midtown Clinic, Sacramento, California, United States

Pediatric Migraine

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of modera…

Birmingham, United StatesEst. completion Jan 9, 2029

MigraineMigraine With AuraMigraine Without Aura

This study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program c…

San Francisco, United StatesEst. completion Oct 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.